Two Sigma Advisers LP purchased a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 280,764 shares of the real estate investment trust's stock, valued at approximately $5,691,000.
Other hedge funds have also bought and sold shares of the company. Mizuho Bank Ltd. bought a new position in Healthpeak Properties in the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd bought a new stake in Healthpeak Properties in the fourth quarter worth $30,000. Covestor Ltd grew its position in Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,152 shares during the last quarter. Kestra Investment Management LLC bought a new position in Healthpeak Properties during the 4th quarter worth approximately $45,000. Finally, Kapitalo Investimentos Ltda purchased a new position in shares of Healthpeak Properties in the fourth quarter worth $46,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Healthpeak Properties
In related news, Director Tommy G. Thompson purchased 5,777 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average price of $17.27 per share, with a total value of $99,768.79. Following the completion of the acquisition, the director now owns 144,290 shares in the company, valued at $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John T. Thomas purchased 4,200 shares of the business's stock in a transaction that occurred on Monday, April 28th. The stock was bought at an average cost of $17.84 per share, with a total value of $74,928.00. Following the acquisition, the director now owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 29,764 shares of company stock worth $521,909 over the last quarter. 0.23% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several brokerages have commented on DOC. Robert W. Baird decreased their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Scotiabank cut their price objective on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research report on Monday, May 12th. Evercore ISI cut their price objective on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Wedbush cut their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Finally, Argus restated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $23.45.
Get Our Latest Analysis on DOC
Healthpeak Properties Stock Up 0.3%
Shares of DOC traded up $0.06 during trading hours on Wednesday, hitting $17.41. The company had a trading volume of 10,144,615 shares, compared to its average volume of 5,106,564. The company has a market capitalization of $12.10 billion, a PE ratio of 49.74, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a one year low of $16.64 and a one year high of $23.26. The company's fifty day moving average price is $18.28 and its two-hundred day moving average price is $19.79.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. During the same period in the prior year, the firm earned $0.45 EPS. The firm's revenue was up 15.9% on a year-over-year basis. As a group, equities analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The business also recently announced a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be paid a $0.1017 dividend. The ex-dividend date is Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties's payout ratio is 305.00%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.